Free Trial
NYSEAMERICAN:STXS

Stereotaxis (STXS) Stock Price, News & Analysis

Stereotaxis logo
$1.80 -0.08 (-4.26%)
Closing price 03/28/2025 04:10 PM Eastern
Extended Trading
$1.80 +0.00 (+0.28%)
As of 03/28/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Stereotaxis Stock (NYSEAMERICAN:STXS)

Key Stats

Today's Range
$1.80
$1.88
50-Day Range
$1.77
$2.56
52-Week Range
$1.66
$3.29
Volume
370,742 shs
Average Volume
370,853 shs
Market Capitalization
$152.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Remove Ads

Stereotaxis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

STXS MarketRank™: 

Stereotaxis scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Stereotaxis.

  • Earnings Growth

    Earnings for Stereotaxis are expected to grow in the coming year, from ($0.26) to ($0.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stereotaxis is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stereotaxis is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Stereotaxis has a P/B Ratio of 9.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Stereotaxis' valuation and earnings.
  • Percentage of Shares Shorted

    6.15% of the float of Stereotaxis has been sold short.
  • Short Interest Ratio / Days to Cover

    Stereotaxis has a short interest ratio ("days to cover") of 8.6.
  • Change versus previous month

    Short interest in Stereotaxis has recently increased by 16.04%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Stereotaxis does not currently pay a dividend.

  • Dividend Growth

    Stereotaxis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.15% of the float of Stereotaxis has been sold short.
  • Short Interest Ratio / Days to Cover

    Stereotaxis has a short interest ratio ("days to cover") of 8.6.
  • Change versus previous month

    Short interest in Stereotaxis has recently increased by 16.04%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Stereotaxis has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Stereotaxis this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for STXS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Stereotaxis to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stereotaxis insiders have bought more of their company's stock than they have sold. Specifically, they have bought $110,951.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    18.52% of the stock of Stereotaxis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    45.35% of the stock of Stereotaxis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stereotaxis' insider trading history.
Receive STXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stereotaxis and its competitors with MarketBeat's FREE daily newsletter.

STXS Stock News Headlines

Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
Stereotaxis says Nvidia highlighted technology at NVIDIA GTC
Stereotaxis (STXS) Gets a Buy from Lake Street
See More Headlines

STXS Stock Analysis - Frequently Asked Questions

Stereotaxis' stock was trading at $2.29 at the beginning of 2025. Since then, STXS shares have decreased by 21.4% and is now trading at $1.80.
View the best growth stocks for 2025 here
.

Stereotaxis, Inc. (NYSEAMERICAN:STXS) posted its earnings results on Monday, November, 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.03. The business had revenue of $9.20 million for the quarter, compared to analyst estimates of $6.80 million. Stereotaxis had a negative net margin of 85.79% and a negative trailing twelve-month return on equity of 162.54%.

Top institutional shareholders of Stereotaxis include Lagoda Investment Management L.P. (4.87%), Redmile Group LLC (2.12%), Geode Capital Management LLC (1.65%) and Essex Investment Management Co. LLC (1.43%).
View institutional ownership trends
.

Shares of STXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stereotaxis investors own include Tesla (TSLA), Advanced Micro Devices (AMD), NVIDIA (NVDA), Intel (INTC), Meta Platforms (META), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/11/2024
Today
3/29/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:STXS
Employees
130
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-20,710,000.00
Pretax Margin
-85.79%

Debt

Sales & Book Value

Annual Sales
$26.77 million
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
9.00

Miscellaneous

Free Float
69,038,000
Market Cap
$152.51 million
Optionable
Not Optionable
Beta
1.54
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSEAMERICAN:STXS) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners